Evidence map›Paper›PMID 25185545›Full record

ArticleBiophysical journal2014

The tetramerization domain potentiates Kv4 channel function by suppressing closed-state inactivation.

Yi-Quan Tang, Jing-Heng Zhou, Fan Yang, Jie Zheng, KeWei Wang

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yi-Quan TangDepartment of Molecular and Cellular Pharmacology, State Key Laboratory of Natural and Biomimetic Drugs, Peking University School of Pharmaceutical Sciences, Beijing, China.
Jing-Heng ZhouDepartment of Molecular and Cellular Pharmacology, State Key Laboratory of Natural and Biomimetic Drugs, Peking University School of Pharmaceutical Sciences, Beijing, China.
Fan YangDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California.
Jie ZhengDepartment of Physiology and Membrane Biology, University of California School of Medicine, Davis, California.
KeWei WangDepartment of Molecular and Cellular Pharmacology, State Key Laboratory of Natural and Biomimetic Drugs, Peking University School of Pharmaceutical Sciences, Beijing, China; PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China. Electronic address: wangkw@hsc.pku.edu.cn.
Peking University · CNUniversity of California, Davis · USChinese Institute for Brain Research · CN

Funding

Molecular Mechanism of pH Regulation of TRPV1 ActivationR01NS072377 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZHENG, JIE · 2011 to 2015
$1.7M
NINDS NIH HHS R01 NS072377
6 · The paper itself

Abstract

A-type Kv4 potassium channels undergo a conformational change toward a nonconductive state at negative membrane potentials, a dynamic process known as pre-open closed states or closed-state inactivation (CSI). CSI causes inhibition of channel activity without the prerequisite of channel opening, thus providing a dynamic regulation of neuronal excitability, dendritic signal integration, and synaptic plasticity at resting. However, the structural determinants underlying Kv4 CSI remain largely unknown. We recently showed that the auxiliary KChIP4a subunit contains an N-terminal Kv4 inhibitory domain (KID) that directly interacts with Kv4.3 channels to enhance CSI. In this study, we utilized the KChIP4a KID to probe key structural elements underlying Kv4 CSI. Using fluorescence resonance energy transfer two-hybrid mapping and bimolecular fluorescence complementation-based screening combined with electrophysiology, we identified the intracellular tetramerization (T1) domain that functions to suppress CSI and serves as a receptor for the binding of KID. Disrupting the Kv4.3 T1-T1 interaction interface by mutating C110A within the C3H1 motif of T1 domain facilitated CSI and ablated the KID-mediated enhancement of CSI. Furthermore, replacing the Kv4.3 T1 domain with the T1 domain from Kv1.4 (without the C3H1 motif) or Kv2.1 (with the C3H1 motif) resulted in channels functioning with enhanced or suppressed CSI, respectively. Taken together, our findings reveal a novel (to our knowledge) role of the T1 domain in suppressing Kv4 CSI, and that KChIP4a KID directly interacts with the T1 domain to facilitate Kv4.3 CSI, thus leading to inhibition of channel function.

Indexed as

AnimalsBiotinylationBlotting, WesternFluorescence Resonance Energy TransferHEK293 CellsHumansKv Channel-Interacting ProteinsMembrane PotentialsMicroscopy, ConfocalOocytesPatch-Clamp TechniquesPolymethacrylic AcidsQuaternary Ammonium CompoundsShal Potassium ChannelsTransfectionXenopus laevisKv Channel-Interacting ProteinsPolymethacrylic Acidspoly-omega-methacryloyloxyundecyltrimethylammonium bromideQuaternary Ammonium CompoundsShal Potassium Channels

Identifiers

PMID25185545
PMCPMC4156681
OpenAlexW1982447748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.